Fondazione VIDAS, Via U. Ojetti 66, 20151, Milan, Italy.
Renal Division, ASST Santi Paolo e Carlo, Milan, Italy.
J Nephrol. 2024 Apr;37(3):661-669. doi: 10.1007/s40620-023-01879-3. Epub 2024 Mar 6.
Kidney supportive care is an interdisciplinary model of person-centred medicine, suitable for patients with advanced Chronic Kidney Disease (CKD) and with End-Stage Kidney Disease (ESKD). There is little information on routine care, and palliative care remains poorly integrated into standard nephrology care. The aim of this study was to describe our experience in integrating a palliative care approach into the nephrology care of advanced chronic and end-stage kidney disease.
A retrospective cohort study was conducted from 1 June, 2017 until 31 December, 2020 on 67 advanced CKD and ESKD patients admitted to a palliative care service.
The patients' median age was 83.6 years, 62.7% were male, 16.4% had CKD stage 4 and 83.6% stage 5. Almost half (47.8%) of the patients were on kidney replacement therapy, and 52.2% were on conservative therapy. The majority (77.6%) received home-based palliative care, 17.9% hospice care and 4.5% day-hospice care. The median number of nephrologists' visits per patient was 3.5. Access to palliative care specialists was set at 100% and the median number of palliative clinicians' visits was 8. Eighty-five percent of patients did not require hospitalisation and 94% did not access to the emergency room; 86.2% of the patients died in hospice or at home.
This study reports on the first steps taken to change practice in nephrology, by applying the Italian guideline for an integrated pathway of palliative care in nephrology. Nephrologists' and the palliative care team created a multi- and inter-disciplinary team, sharing their professional skills to support patients in hospice or at home.
肾脏支持治疗是一种以患者为中心的医学多学科模式,适用于晚期慢性肾脏病(CKD)和终末期肾病(ESKD)患者。关于常规护理的信息很少,姑息治疗在标准肾病护理中的整合仍很差。本研究旨在描述我们将姑息治疗方法整合到晚期慢性和终末期肾病的肾病护理中的经验。
对 2017 年 6 月 1 日至 2020 年 12 月 31 日期间纳入姑息治疗服务的 67 例晚期 CKD 和 ESKD 患者进行回顾性队列研究。
患者的中位年龄为 83.6 岁,62.7%为男性,16.4%为 CKD 4 期,83.6%为 5 期。近一半(47.8%)的患者接受肾脏替代治疗,52.2%接受保守治疗。大多数(77.6%)患者接受家庭姑息治疗,17.9%接受临终关怀,4.5%接受日间临终关怀。每位患者的肾脏科医生就诊中位数为 3.5 次。姑息治疗专家的就诊率为 100%,姑息治疗临床医生的就诊中位数为 8 次。85%的患者无需住院,94%的患者无需到急诊室就诊;86.2%的患者在临终关怀或家中死亡。
本研究报告了意大利肾病姑息治疗综合路径指南应用于肾病学实践改变的第一步。肾病医生和姑息治疗团队创建了一个多学科和跨学科团队,分享他们的专业技能,以支持患者在临终关怀或家中。